COSM News and Press, Cosmos Health Inc.

Oliv18™ expands the 18 Series with a USDA and EU organic certified, 100% solvent-free, whole olive polyphenol formulation from the Moroccan Saharan desert Hydroxytyrosol — the key active in Oliv18™ — is the highest ORAC polyphenol A single 250 mg daily dose meets EFS...

CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”)  (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now available for shipmen...

Company identifies real estate, digital assets, and marketable securities, among others, as potential sources of liquidity — with a combined value of approximately $20 million Proceeds could fund a meaningful acquisition or eliminate debt entirely Company remains fully committed to its c...

Significant Deleveraging: Total liabilities decreased by $4.5 million, or 9.6%, quarter-over-quarter, while stockholders' equity increased 7.6% Landmark Financing: R&D division in discussions with the European Investment Bank for financing of up to €25 million Capital Str...

CHICAGO, June 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the extension of its C-Scrub antimicrobial wash brand into the ve...

Revenue increasing 207% at a 32% CAGR: From $65.3 million in 2025 to $200.6 million by 2029, driven by strong growth across all core segments Gross profit growing 801% to $71.2M: Margins expanding from 12.1% to 35.5% — driven by a structural shift toward high-margin proprietary segment...

No dilution to existing shareholders Reduction in total outstanding warrant overhang Simplifies capital structure CHICAGO, IL / ACCESS Newswire / May 21, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM) , a diversified, vertically integrated ...

2026-05-21 11:26:44 ET More on Cosmos Holdings Cosmos Holdings Non-GAAP EPS of -$0.12, revenue of $65.27M Seeking Alpha’s Quant Rating on Cosmos Holdings Historical earnings data for Cosmos Holdings Financial information for Cosmos Holdings R...

Record Q1 revenue of $17.9M, up 31% from $13.71 million in Q1 2025, reflecting strength across all core segments Total liabilities decreased by $4.5M, or 9.6% , driven by a substantial reduction in convertible note and credit facility balances Stockholders' equity increased by $1.4M, or ...

Cosmos Health Inc. (COSM) is expected to report $-0.01 for Q1 2026